duced activation of postsynaptic GIRK-1 channel currents and the presynaptic inhibition of glutamatergic neurotransmission. These effects were observed in identified POMC neurons, including eight that projected to the MPN. Taken together, these data reveal that estradiol attenuates the pleiotropic inhibitory actions of OFQ/N on POMC neurons: presynaptically through reducing the OFQ/N inhibition of glutamate release and postsynaptically by reducing ORL1 signaling through GIRK channels. As such, they impart critical insight into a mechanism for estradiol to increase the activity of POMC neurons that inhibit sexual receptivity.
Introduction
Orphanin FQ (a.k.a., nociceptin (OFQ/N)) is a heptadecapeptide that activates a metabotropic, G i/o -coupled receptor termed the opioid receptor-like (ORL)1 receptor [1] [2] [3] . Being G i/o -coupled, the ORL1 receptor regulates cell excitability by augmenting postsynaptic K + currents, decreasing postsynaptic Ca 2+ currents, and presynaptically inhibiting neurotransmitter release. For example, OFQ/N elicits an ORL1 receptor-mediated activation of G protein-gated, inwardly rectifying K + (GIRK) currents in the locus coeruleus [4] , periaqueductal gray [5] , nucleus raphe magnus [6] , as well as the ventromedial (VMN) [7, 8] , suprachiasmatic (SCN) [9] , tubero mammillary [10] and arcuate (ARH) [7, 11, 12] nuclei of the hypothalamus. OFQ/N also inhibits voltage-gated, L-and Ntype Ca 2+ currents in hippocampal neurons [13] , T-type currents in the dorsal root ganglion cells [14] and N-and P/Q-type currents in the SCN [15] . In addition, OFQ/N presynaptically inhibits excitatory glutamatergic input in the ARH [7, 12] as well as both glutamatergic and inhibitory γ-aminobutyric acid (GABA)ergic input in the SCN [15] and lateral amygdala [16] .
While it is clear that the ORL1 receptor is distributed throughout the central nervous system, its expression is particularly abundant in the hypothalamus [1, 17, 18] . In situ hybridization and OFQ/N-stimulated [ 35 S]GTPγS binding studies have revealed intense ORL1 expression in the medial preoptic nucleus (MPN), paraventricular nucleus, ARH and VMN [1, 17, 18] . Accordingly, OFQ/N is thought to play an important role in regulating functions controlled by the hypothalamus like energy balance and reproduction [19, 20] . Regarding the latter, the current available evidence implicates OFQ/N in mediating ovarian steroid-induced changes in female sexual behavior [20, 21] . Sexual receptivity (as assessed using lordosis) is modulated via a hypothalamic-limbic circuit comprising the VMN, the ARH, the medial amygdala and the MPN [21] [22] [23] . One of the most important neuroanatomical substrates within this circuit is the subpopulation of proopiomelanocortin (POMC) neurons that have cell bodies in the ARH and project to the MPN. These cells release the endogenous opioid peptide β-endorphin that activates μ-opioid receptors expressed on MPN neurons. Estradiol has long been known to increase the release of β-endorphin during the follicular period of the primate ovarian cycle [24] , and when administered to ovariectomized rodents and primates it increases β-endorphin expression [25] and release [22, 24] . Thus, estradiol rapidly activates this circuit to stimulate release of β-endorphin from ARH POMC neurons in the MPN to activate μ-opioid receptors and inhibit sexual receptivity [21-23, 26, 27] . This estrogenic effect is a requisite step for the subsequent development of sexual receptivity [22, 23] .
Estradiol has been shown to rapidly negatively modulate the coupling of inhibitory metabotropic receptors to their effector systems in hypothalamic neurons. For example, in POMC neurons estradiol attenuates the activation of postsynaptic GIRK channels elicited by stimulation of G i/o -coupled μ-opioid and GABA B receptors [28] [29] [30] , as well as the activation of postsynaptic Kv4.2 channels caused by stimulation of cannabinoid CB1 receptors [31, 32] , in a rapid and sustained fashion. Estradiol also diminishes the CB1 receptor-mediated presynaptic inhibition of glutamatergic input to these cells [32, 33] . Given that OFQ/N inhibits the considerable majority of ARH neurons, including POMC neurons [7, 11, 12] , and that it plays a role in mediating ovarian steroid-induced changes in female sexual behavior through ARH POMC neurons that project to the MPN [20, 21, 23] , we tested the hypothesis that estradiol reduces the pre-and postsynaptic ORL1 receptor-mediated actions that inhibit the excitability of these cells.
Materials and Methods

Animals
Adult Long-Evans female rats (200-225 g) were purchased from Charles River Laboratory, Inc. (Wilmington, Mass., USA). Bilateral ovariectomies (OVX) were performed by the supplier. Animals were housed in a climate-and light-controlled room (12/12 L/D cycle, lights on 07: 00 h) with food and water available ad libitum. All procedures were approved by the Western University of Health Sciences IACUC in accordance with institutional guidelines based on NIH standards. Animals were treated once every 4 days for three cycles with either estradiol benzoate (EB; 2 μg, s.c.) or its sesame oil vehicle (0.1 ml total volume, s.c.). Brains were collected 30 h after the final EB/vehicle treatment. This treatment paradigm mimics the peak levels of estradiol that are produced on the afternoon of proestrus and does not facilitate sexual receptivity without subsequent progesterone or pharmacological manipulation [21, 23, 26, 34, 35] . Further, this estradiol priming paradigm activates the inhibitory ARH-MPN reproductive behavior circuit while priming other mechanisms that are involved in the facilitation of lordosis and has been used by us and others to study the physiology of steroid regulation of female sexual receptivity and feeding [18, 27, [34] [35] [36] .
Drugs
Unless otherwise indicated, all drugs were purchased through Tocris Cookson, Inc. (Ellisville, Mo., USA). EB (Steraloids, Newport, R.I., USA) was initially prepared as a 1-mg/ml stock solution in punctilious ethanol. A known quantity of this stock solution was added to a volume of sesame oil sufficient to produce a final concentration of 20 μg/ml of EB. OFQ/N, the ORL1 receptor antagonist UFP-101, the voltage-gated Na + channel blocker tetrodotoxin (TTX) with citrate (Alomone Labs Ltd, Jerusalem, Israel), the GIRK channel blocker tertiapin (Alomone Labs Ltd), the GABA A receptor antagonist 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR 95531) and the α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) were dissolved in UltraPure H 2 
Stereotaxic Surgery
Some animals were focally injected with the retrograde tracer Fluorogold (Fluorochrome; LLC, Denver, Colo., USA) into the MPN 6-8 days prior to experimentation. They were fitted in a stereotaxic apparatus (Digital Lab Standard; Stoelting Co., Wood Dale, Ill., USA) while under 3% isoflurane anesthesia. The scalp was opened with a 2-to 2.5-cm incision made down the midline of the skull beginning at the front of the orbits towards the occipital lobe with a scalpel blade. The periosteum was rubbed from the scalp by sterile cotton swabs. A single hole was drilled so that an infusion needle could be slowly lowered into the MPN (coordinates from bregma, anterior -0.1 mm, lateral -0.8 mm, and ventral -6.0 mm from dura; tooth bar -3.3 mm). The infusion needle was held at these coordinates for 1 min prior to the start of infusion. The retrograde tract tracer, Fluorogold (5% dissolved in sterile saline; 0.5 μl total volume), was slowly injected into the MPN using a Stoelting manual injector system. The infusion needle remained in place for 10 min after infusion to allow for diffusion from the tip and then slowly removed from the brain to reduce potential spread of Fluorogold. Sterile bone wax was placed in the hole to seal the cavity and help promote clotting. After surgery, the rats were given oral antibiotics in drinking water (0.5 mg/ml of sulfamethoxazole and 0.1 mg/ml of trimethoprim; Hi-Tech Pharmacal, Amityville, N.Y., USA) as well as Carprofen (5 mg/kg, s.c.; Sigma Aldrich Corp., St. Louis, Mo., USA) to help control postoperative pain.
Electrophysiology
On the day of experimentation, the OVX rat was anesthetized with isoflurane, decapitated, brain removed from the skull and the hypothalamus dissected. The hypothalamic block was mounted on a cutting platform, secured in a vibratome well filled with an icecold, oxygenated (95% O 2 , 5% CO 2 ) artificial cerebrospinal fluid (aCSF) in which the majority of sodium was replaced by sucrose (sucrose, 208; NaHCO 3 , 26; KCl, 2; NaH 2 PO 4 , 1.25; dextrose, 10; HEPES, 10; MgSO 4 , 2; MgCl 2 1; CaCl 2 , 1; in m M ). Three to four coronal slices (300 μ m ) through the rostrocaudal extent of the ARH were cut at 1 ° C. The slices were then transferred to an auxiliary chamber and incubated at room temperature in oxygenated aCSF containing (in m M ): NaCl, 124; NaHCO 3 , 26; dextrose, 10; HEPES, 10; KCl, 5; NaH 2 PO 4 , 2.6; MgSO 4 , 2; CaCl 2 , 1. They were kept under these conditions until electrophysiological recording.
During whole-cell patch recording from ARH neurons, slices were maintained in a chamber perfused with a warmed (35 ° C), oxygenated aCSF in which the CaCl 2 concentration was raised to 2 m M . Artificial CSF and all drugs (diluted with aCSF) were perfused via a peristaltic pump at a rate of 1.5 ml/min. Patch electrodes are assembled from borosilicate glass (World Precision Instruments, Sarosota, Fla., USA; 1.5 mm OD) pulled on a P-97 Flaming Brown puller (Sutter Instrument Co., Novato, Calif., USA), and filled with the following (in m M ): potassium gluconate, 128; NaCl, 10; MgCl 2 , 1; EGTA, 11; HEPES, 10; ATP, 1; GTP, 0.25; 0.5% biocytin; adjusted to a pH of 7.3 with KOH. Electrode resistances vary from 3 to 8 MΩ. A Multiclamp 700A preamplifier (Axon Instruments, Foster City, Calif., USA) amplified potentials and passed current through the electrode. Membrane currents were recorded in voltage clamp with access resistances that typically range from 8 to 22 MΩ, and underwent analog-digital conversion via a Digidata 1322A interface coupled to pClamp 8.2 software (Axon Instruments). The access resistance, as well as the resting membrane potential (RMP) and the input resistance (R in ), were monitored throughout the course of the recording. If the access resistance deviated greater than 10% of its original value, the recording was ended. Low-pass filtering of the currents was conducted at a frequency of 2 kHz. The liquid junction potential was calculated to be -10 mV, and corrected for during data analysis using pClamp software.
In studies designed to evaluate the effect of OFQ/N on the firing of ARH neurons, we examined spontaneous activity in the cellattached configuration under basal conditions, in the presence of 1 μ M OFQ/N, and during the clearance of the neuropeptide from the slice. The interspike interval was measured from at least 100 contiguous action potentials. The distributions obtained prior to and in the presence of OFQ/N were evaluated using quantile plots and the Kolmogorov-Smirnov test.
To determine whether OFQ/N activates postsynaptic K + currents that are highly prevalent in ARH neurons, recordings using the whole-cell configuration from holding potentials of -60 mV were performed. OFQ/N was perfused along with 1 μ M TTX until a new steady-state holding current was established (3-5 min). Current-voltage relationships were generated before and immediately following peptide application over a range centering on the equilibrium potential for K + . This is accomplished with step command potentials ranging from -50 to -130 mV (1 s duration, 10-mV increments). Blockade of the OFQ/N-induced outward current by either UFP-101 (100 n M ) or tertiapin (10 n M ) served as the indication that the effect was due to the activation of ORL1 receptors and GIRK-1 channels, respectively.
To evaluate if OFQ/N presynaptically inhibits glutamatergic neurotransmission at ARH synapses, we recorded miniature excitatory postsynaptic currents (mEPSCs) in the presence of both the GABA A receptor antagonist SR 95531 (10 μ M ) and TTX (500 n M ) from a holding potential of -75 mV using an internal solution in which Cs + was substituted for K + . After collecting a 3-to 4-min segment of baseline data, we perfused OFQ/N (100 n M -1 μ M ) for 4 min, and then recorded mEPSCs in the presence of the peptide. The threshold for mEPSC detection was set at least 3 pA below the baseline holding current as assessed from the headstage output, and continuously monitored throughout each 3-to 4-min recording period. Information on interval and amplitude was obtained from at least 100 contiguous mEPSCs, which we used to evaluate OFQ/Ninduced alterations in mEPSC frequency and amplitude as assessed from cumulative probability plots. We verified that the mEPSCs were due to the activation of ionotropic glutamate receptors by testing in the presence of NBQX (3 μ M ) and CGS 19755 (10 μ M ).
Immunohistochemistry
Following electrophysiological recording, slices were fixed with 4% paraformaldehyde in Sorensen's phosphate buffer (pH 7.4) for 90-180 min [37] . They then were immersed overnight in 20% sucrose dissolved in Sorensen's buffer, and frozen in Tissue-Tek embedding medium (Miles, Inc., Elkhart, Ind., USA) the next day. Coronal sections (20 μm) were cut on a cryostat and mounted on slides. These sections were washed with 0.1 M sodium phosphate buffer (pH 7.4) and then processed with streptavidin-Alexa Fluor (AF) 488 (Molecular Probes, Inc., Eugene, Oreg., USA) at a 1: 300 dilution. After localizing the biocytin-filled neuron via fluorescence microscopy, the slides containing the appropriate sections were processed with a polyclonal antibodies directed against either β-endorphin or α-melanocyte-stimulating hormone (Immunostar, Inc., Hudson, Wisc., USA; 1: 400 or 1: 200 dilution, respectively) using fluorescence immunohistochemistry [37] .
Statistical Analyses
Comparisons between two groups were made with either the Student's t test or the Mann-Whitney W test. Comparisons between more than two groups were performed using either the oneway, multifactorial or rank-transformed two-way analysis of variance (ANOVA) followed by the least significant difference (LSD) test, or alternatively via the Kruskal-Wallis test followed by analysis of the median-notched, box-and-whisker plot. Comparisons of the mEPSC interval distributions observed under basal and OFQ/N-treated conditions were evaluated via the KolmogorovSmirnov test. Differences were considered statistically significant if the probability of error was <5%.
Results
Recordings were made from a total of 86 ARH neurons in slices obtained from animals 30 h after being treated with either EB (2 μg, s.c.) or its sesame oil vehicle. EB had no effect on either the RMP (vehicle -52.8 ± 1.5 mV; EB -52.0 ± 2.1 mV; n = 35-51) or R in (vehicle 525.0 ± 79.8 MΩ; EB 507.4 ± 50.9 MΩ; n = 34-51). It did, however, significantly elevate the basal mEPSC frequency (vehicle 7.8 ± 1.2 Hz; EB 13.7 ± 3.0 Hz; n = 5-17; Student's t test, t = -2.13104, p < 0.05) without any concomitant change in mEPSC amplitude (vehicle -11.3 ± 0.7 pA; EB -9.4 ± 0.6 pA; n = 5-17; Student's t test, t = -1.46563, p < 0.16).
Experiment 1: Estrogenic Modulation of the ORL1 Receptor-Mediated Activation of Postsynaptic GIRK-1 Channels
To investigate whether estradiol influences the ability of OFQ/N to inhibit rat ARH neurons via activation of GIRK-1 channels, patch-clamp recordings were made in hypothalamic slices using biocytin-filled electrodes. OFQ/N (1 μ M ) application produced a significant reduction in the firing frequency ( fig. 1 a) 
Experiment 2: Estrogenic Modulation of the ORL1 Receptor-Mediated Presynaptic Inhibition of Glutamatergic Neurotransmission
To determine whether estradiol also alters OFQ/N-induced presynaptic inhibition of glutamatergic input onto ARH neurons, we evaluated mEPSC frequency and amplitude in slices collected from EB-and vehicle-treated female rats. In ARH neurons from vehicle-treated animals, OFQ/N (1 μ M ) produced a substantial increase in * * For a , due to the fact that the onset of the original response was 3 min into the OFQ application, we waited until 2 min after the OFQ + UFP-101 application before beginning the data acquisition (to save bandwidth). Therefore, the end of the trace in the right panel is actually 5 min into the OFQ + UFP-101 application, at which point we see no change in the holding current. Moreover, after the second I/V, we monitored the holding current for an additional 7 min in the presence of OFQ + UFP-101 before detaching from the cell, and we still did not see any change.
We attempted to identify 30 of the 86 ARH neurons evaluated in the present study after electrophysiological recording. Of these, 20 cells were immunocytochemically identified using phenotypic markers of POMC neurons, whereas 10 cells were immunonegative for these markers. The pleiotropic actions of OFQ/N, and their negative modulation by EB, were observed in these 20 POMC neurons, including eight MPN-projecting POMC neurons that were labeled with Fluorogold in their perikarya ( fig. 8 ) . Table 1 summarizes these effects on POMC neurons and unidentified ARH neurons in slices from vehicle-and EB-treated rats. It is noteworthy that the OFQ/N-induced outward current and increase in slope conductance are considerably more robust in POMC neurons than in unidentified ARH neurons, whereas the decrease in mEPSC frequency is comparable between the two populations. 
Discussion
The results of the present study demonstrate that the in vivo administration of estradiol 30 h prior to experimentation negatively modulates the postsynaptic inhibitory effects of ORL1 activation on POMC neurons that project to the MPN, as well as the presynaptic inhibition of glutamatergic excitatory input impinging upon them. This conclusion is based on the following observations: (1) OFQ/N elicited a robust outward current in identified, Fluorogold-filled POMC neurons from OVX, vehicle-treated animals that was blocked by the ORL1 receptor antagonist, UFP-101 and the GIRK channel blocker tertiapin, and markedly attenuated in POMC neurons from EB-treated animals; (2) OFQ/N decreased the frequency of mEPSCs in POMC neurons from vehicle-treated animals that were abolished by ionotropic glutamate receptor antagonists, and (3) this OFQ/N-induced decrease in glutamate release at POMC synapses was blocked by UFP-101, and significantly reduced in EB-treated animals.
The ORL1 receptor-mediated activation of GIRK that we observed in the present study is consistent with that described elsewhere in the central nervous system including, but not limited to, the locus coeruleus [4] , the periaqueductal gray [5] , the nucleus raphe magnus [6] , the tuberomammillary nucleus [10] , the SCN [9] , the VMN [7, 8] and the ARH [7, 11, 12] . This ORL1 receptor-mediated activation of GIRK-1 channels presently seen in the overwhelming majority of rat ARH neurons is virtu- ally indistinguishable from that reported for guinea pigs and mice. In the guinea pig, the OFQ/N-induced hyperpolarization and outward current encountered in POMC neurons was blocked by Ba 2+ [11] , whereas in the mouse [12] and presently in the rat it is antagonized by tertiapin. While it is true that tertiapin did not completely block the OFQ/N-induced activation of GIRK-1 channels, it is clear from looking at figure 1 in its totality that it did markedly attenuate the response. This observation points to the critical role that GIRK-1 channels play in inhibiting POMC neurons. Perhaps a higher dose would have fully antagonized the response. Alternatively, OFQ/N can also inhibit an array of voltage-gated Ca 2+ channels [13] [14] [15] . Perhaps the OFQ/N-induced inhibition of these voltagegated Ca 2+ channels and/or activation of (an)other type(s) of K + channel(s) (e.g. KATP channels) contribute to the OFQ/N-induced decrease in neuronal excitability. In addition, the profound inhibition of the GIRK currents caused by UFP-101 is comparable to that seen in ORL1 receptor knockout mice [12] . Likewise, the ORL1 receptor-mediated decrease in the frequency of mEPSCs impinging upon POMC neurons is in agreement with that described in the SCN [15] , the lateral amygdala [16] and the ARH [12] . Moreover, the lack of effect at rat POMC synapses seen presently following co-treatment with UFP-101 is nearly identical to that reported in ORL1 receptor knockout mice [12] . These latter two findings, coupled with the fact that we and others have shown that OFQ/N decreases presynaptic Ca 2+ concentrations, reduces evoked EPSC amplitude and increases the S2/S1 ratio, is indicative of a presynaptic effect due likely to an ORL1 receptor-mediated attenuation of Ca 2+ influx through voltage-gated channels [7, 12, 15, 16] . Arguably the principal function of the GIRK-1 channel is to produce a hyperpolarization of the plasma membrane that decreases the likelihood that the threshold for the activation of voltage-gated Na + channels will be reached, thereby decreasing the firing rate or causing a cessation of action potential firing altogether [38] . Likewise, the spontaneous EPSCs caused by the activation of ionotropic glutamate receptors brings the membrane potential closer to the threshold for the activation of voltage-gated Na + channels, thereby increasing the probability that an ac- 69 tion potential will be generated [39] [40] [41] [42] . Thus, this pleiotropic activation of postsynaptic GIRK channels in POMC neurons, concomitant with decreased glutamate release from upstream nerve terminals, undoubtedly leads to a powerful inhibition of POMC excitability. Of course, the estrogenic uncoupling of ORL1 receptors from their effector systems would increase the excitability of POMC neurons. First, we show that estradiol diminishes ORL1 receptor-mediated activation of postsynaptic GIRK channels in POMC neurons, which would reduce outward K + currents that could hyperpolarize and thereby decrease the firing rate of POMC neurons. This is congruent with previously documented accounts of estradiol-induced uncoupling of μ-opioid and GABA B receptors from their GIRK channels in POMC neurons, which can be attributed to the activation of a phosphatidylinositol-3-kinase (PI3K)/phospholipase C/protein kinase C (PKC)/protein kinase A (PKA) pathway [30, 43, 44] . We also observed that estradiol per se increased the glutamatergic synaptic input onto POMC neurons. This is consistent with the fact that (1) estrogen receptors colocalize with AMPA receptor GluR1 subunits in over 50% of ARH neurons [45] ; (2) estradiol increases asymmetric synapse formation in the ARH [46] and in cultured hippocampal neurons [47] ; (3) estradiol increases AMPA receptor subunit expression in the hypothalamus [45] ; (4) estradiol stimulates dendritic spine formation in the VMN, the ARH and the hippocampus by mechanisms that appear to involve PI3K, metabotropic glutamate receptor signaling and a reduction in inhibitory GABAergic neurotransmission [48] [49] [50] , and (5) estradiol presynaptically facilitates glutamate release in developing hypothalamic neurons via the activation of PI3K [49] . Estradiol also acts through estrogen receptor (ER)α and ERβ in the hippocampus, and ERα in the hypothalamus, to enhance metabotropic glutamate receptor signaling [49, 51] . Lastly, we found that estradiol suppressed the ORL1 receptormediated presynaptic inhibition of glutamatergic input, which is in keeping with the fact that the steroid activates ERα and the G q -coupled membrane ER to diminish CB1 receptor-mediated inhibition of glutamate release at POMC synapses via PI3K, PKCδ and, to a lesser extent, PKA [52, 53] . Coupled with considerable precedence for estradiol-induced changes in Ca 2+ flux and mobilization in hypothalamic neurons and glia [54] [55] [56] , it is certainly possible that the steroid is interfering with the mechanism through which presynaptic ORL1 receptors decrease Ca 2+ influx into the nerve terminal. Given that estradiol is functionally disengaging the ORL1 receptor from the effector systems that hyperpolarize POMC neurons and decrease glutamatergic input impinging upon these cells, we interpret this by concluding that the steroid lessens the hyperpolarization and lessens the inhibition of glutamatergic input, thereby increasing the excitability of POMC neurons. The ability of estradiol to diminish the μ-opioid and GABA B receptor-mediated activation of GIRK channels in, as well as the CB1 receptor-mediated decrease in glutamate release onto, POMC neurons is both rapid (i.e. it is initially observed within minutes following bath application [29, 32, 30, 43, 44] ) and sustained (i.e. it continues to be seen at least 24 h following systemic administration [28, 33] ). These findings make for a compelling hypothesis that estradiol acts rapidly to uncouple the ORL1 receptor from its effector systems, and this will be tested in future experiments.
Thus, our current findings indicate that estradiol enhances the activity of the POMC neurons that project to the MPN, at least in part, by diminishing postsynaptic activation of GIRK-1 channels and the presynaptic inhibition of glutamate release. It follows logically that the estradiol-induced disruption of the pleiotropic signaling of G i/o -coupled receptors like the ORL1 receptor would serve to increase the release of posttranslational by-products of POMC processing like β-endorphin. Indeed, estradiol increases the release of β-endorphin measured in hypophysial portal blood during the mid-follicular phase of the primate ovarian cycle [24] , and increases β-endorphin expression [25] and release [24] in OVX rodents and primates, respectively. The increased β-endorphin release would stimulate μ-opioid receptors in the MPN which receives the terminal fields of rostrally projecting POMC neurons, leading to their internalization [22, 57] . This activation of POMC neurons occurring prior to ovulation is essential for subsequent female sexual behavior, as pretreatment with the opioid receptor antagonist naltrexone not only blocked the μ-opioid receptor internalization but also compromised sexual receptivity in rats to a degree similar to that observed in μ-opioid receptor knockout mice [22, 58, 59] .
The ability of estradiol to interfere with ORL1 signaling at POMC synapses extends beyond reproductive behavior. ORL1 receptor activation elicits appreciable effects on energy homeostasis. Centrally administered OFQ/N increases food intake and adiposity, and decreases core body temperature and uncoupling protein-1 expression in brown adipose tissue [60] [61] [62] . The hyperphagic effect of OFQ/N is reportedly blocked by the N-terminal tridecapeptide analog [Nphe 1 ]OFQ/N(1-13)NH 2 , by antisense probes directed against the ORL1 receptor, by genetic ORL1 receptor ablation and by comparatively 70 high doses of naloxone or naltrexone [12, 60, 61, 63] . In addition, OFQ/N decreases c-Fos activation in anorexigenic POMC neurons involved in meal termination [64] . This estrogenic diminution of pre-and postsynaptic ORL1 receptor-mediated signaling may very well contribute to the decrease in energy intake caused by the steroid in both humans and rodent animal models [65] [66] [67] [68] .
The multifaceted effects of ORL1 receptor activation observed in the present study inhibited a high percentage of identified POMC neurons (20 immunopositive cells out of 30 tested), many of which also projected to the MPN. It is highly unlikely, however, that other neuronal populations in the ARH were unaffected. Indeed, OFQ/N also hyperpolarizes A 12 dopamine and gonadotropin-releasing hormone neurons in the guinea pig ARH [11] . A 12 dopamine neurons tonically inhibit prolactin secretion from the anterior pituitary [69] , and so therefore OFQ/N-induced decreases in the neuronal activity of these cells are associated with increases in circulating prolactin concentrations [70] . Given the well-known fact that estradiol increases the excitability of A 12 dopamine neurons [69] , it is quite plausible that the decreased ORL1 receptor-mediated signaling observed presently contributes to the activation of these cells. Likewise, the OFQ/N-induced inhibition of GnRH neurons is consistent with decreased GnRH release in medial preoptic and mediobasal hypothalamic slices, as well as decreased circulating levels of luteinizing hormone, from OVX rats [71] . OFQ/N also diminishes the magnitude of the luteinizing hormone surge seen in estradiol-primed, progesterone-treated rats. Moreover, OFQ/N expression in the ARH is decreased during proestrus [72] , at a time when estradiol levels are at their highest, which parallels the estrogenic disruption in ORL1 receptor-mediated signaling that we observed in the present study.
In conclusion, the results of the present study demonstrate that estradiol negatively modulates the inhibitory, pre-and postsynaptic actions of OFQ/N on ARH POMC neurons that project to the MPN and are involved in female sexual receptivity. These data provide insight and a newfound appreciation for how estradiol attenuates the signaling imparted by G i/o -coupled receptors to activate these POMC neurons that are important for reproduction and possibly energy balance.
